The country of origin of crystalline allulose
No Headquarters ruling in this index revokes or modifies this ruling. That is not confirmation that it is still in effect: this index does not hold every Headquarters ruling. Confirm its current status with CBP before relying on it (ruling on CBP CROSS). Text last read from CBP on Nov 21, 2026.
Key passages, quoted from the ruling
- Therefore, it is our opinion that the country of origin of the crystalline allulose will be South Korea.
Ruling text
In your letter dated June 1, 2026, you requested a country of origin ruling on behalf of your client, Daesang Corporation. We referred the information provided to our laboratory for review. We regret the delay. The subject product, crystalline allulose, also known as D-psicose, is used as a sugar substitute in food manufacturing processes. You state that allulose syrup is manufactured in South Korea and subsequently shipped to China for crystallization.
In South Korea, fructose syrup is enzymatically converted into allulose, then purified, separated, and concentrated to produce allulose syrup with a purity level of 95 percent or higher. The allulose syrup is then shipped to China, where it undergoes further concentration, crystallization, and separation to produce crystalline allulose with a purity level of 99 percent or higher. When determining the country of origin, the substantial transformation analysis is applicable.
See, e.g., Headquarters Ruling Letter (“HQ”) H301619, dated November 6, 2018. The test for determining whether a substantial transformation will occur is whether an article emerges from a process with a new name, character, or use different from that possessed by the article prior to processing. See Texas Instruments Inc. v. United States, 681 F.2d 778 (C.C.P.A. 1982). This determination is based on the totality of the evidence.
See National Hand Tool Corp. v. United States, 16 C.I.T. 308 (1992), aff’d, 989 F.2d 1201 (Fed. Cir. 1993). Based on the lab report, a chemical reaction occurs during the manufacturing process in South Korea, while the purification process in China does not involve a chemical reaction. Therefore, it is our opinion that the country of origin of the crystalline allulose will be South Korea.
This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov.
The holding set forth above applies only to the specific factual situation and merchandise description as identified in the ruling request. This position is clearly set forth in Title 19, Code of Federal Regulations (CFR), Section 177.9(b)(1). This section states that a ruling letter is issued on the assumption that all of the information furnished in the ruling letter, whether directly, by reference, or by implication, is accurate and complete in every material respect.
In the event that the facts are modified in any way, or if the goods do not conform to these facts at time of importation, you should bring this to the attention of U.S. Customs and Border Protection (CBP) and submit a request for a new ruling in accordance with 19 CFR 177.2. Additionally, we note that the material facts described in the foregoing ruling may be subject to periodic verification by CBP.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N361923).